Insider · CIK 0002144035
Danina Fisher
Files at HEPA (Hepion Pharmaceuticals, Inc.). First filing Oct 2, 2026, latest Oct 2, 2026.
Danina Fisher files SEC Form 4 as director at HEPA (Hepion Pharmaceuticals, Inc.). Since Oct 2, 2026, Danina Fisher has reported 1 open-market buy worth $10k and 0 open-market sells worth $0, the latest filed on Oct 2, 2026.
A track record needs three past buys with six months of prices behind them; Danina Fisher has 0, so none is measured yet.
The newest scored trade: bought $10k of HEPA on Sep 29, 2026, filed Oct 2, 2026, scored 23 (weak). In the last 12 months: 1 buy worth $10k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HEPA: Hepion Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | HEPAbuy Hepion Pharmaceuticals, Inc. | $10k 200,000 shares | - | - |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | HEPA Hepion Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +200,000 | $0.05 | $10k | 200,000 | 11 d ago |
| Sep 29, 2026 | HEPA Hepion Pharmaceuticals, Inc. | POpen-market purchase Warrantsderivative | +200,000 | $0.00 | $0 | 200,000 | 11 d ago |
Questions about Danina Fisher
Answered from the filings on this page, as of the latest one.
Is Danina Fisher buying or selling?
In the last 12 months Danina Fisher reported 1 open-market buy worth $10k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $10k of HEPA on Sep 29, 2026. Grants, option exercises and tax withholding are not counted.
How did Danina Fisher's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Danina Fisher has 0.
Where does Danina Fisher file Form 4?
Danina Fisher has filed Form 4 at HEPA (Hepion Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.